Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection
Gene and drug delivery to the retina is a critical therapeutic goal. While the majority of inherited forms of retinal degeneration affect the outer retina, specifically the photoreceptors and retinal pigment epithelium, effective targeted delivery to this region requires invasive subretinal delivery...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/9/1510 |
_version_ | 1797517540573839360 |
---|---|
author | Aiden Eblimit Mustafa S. Makia Daniel Strayve Ryan Crane Shannon M. Conley Tirthankar Sinha Ghanashyam Acharya Muayyad R. Al-Ubaidi Muna I. Naash |
author_facet | Aiden Eblimit Mustafa S. Makia Daniel Strayve Ryan Crane Shannon M. Conley Tirthankar Sinha Ghanashyam Acharya Muayyad R. Al-Ubaidi Muna I. Naash |
author_sort | Aiden Eblimit |
collection | DOAJ |
description | Gene and drug delivery to the retina is a critical therapeutic goal. While the majority of inherited forms of retinal degeneration affect the outer retina, specifically the photoreceptors and retinal pigment epithelium, effective targeted delivery to this region requires invasive subretinal delivery. Our goal in this work was to evaluate two innovative approaches for increasing both the persistence of delivered nanospheres and their penetration into the outer retina while using the much less invasive intravitreal delivery method. We formulated novel hyaluronic acid nanospheres (HA-NS, 250 nm and 500 nm in diameter) conjugated to fluorescent reporters and delivered them intravitreally to the adult Balb/C mouse retina. They exhibited persistence in the vitreous and along the inner limiting membrane (ILM) for up to 30 days (longest timepoint examined) but little retinal penetration. We thus evaluated the ability of the small molecule, sulfotyrosine, to disrupt the ILM, and found that 3.2 µg/µL sulfotyrosine led to significant improvement in delivery to the outer retina following intravitreal injections without causing retinal inflammation, degeneration, or loss of function. Co-delivery of sulfotyrosine and HA-NS led to robust improvements in penetration of HA-NS into the retina and accumulation along the interface between the photoreceptors and the retinal pigment epithelium. These exciting findings suggest that sulfotyrosine and HA-NS may be an effective strategy for outer retinal targeting after intravitreal injection. |
first_indexed | 2024-03-10T07:17:57Z |
format | Article |
id | doaj.art-0a139b58594443809308ff063f0c6002 |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-10T07:17:57Z |
publishDate | 2021-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-0a139b58594443809308ff063f0c60022023-11-22T14:48:50ZengMDPI AGPharmaceutics1999-49232021-09-01139151010.3390/pharmaceutics13091510Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal InjectionAiden Eblimit0Mustafa S. Makia1Daniel Strayve2Ryan Crane3Shannon M. Conley4Tirthankar Sinha5Ghanashyam Acharya6Muayyad R. Al-Ubaidi7Muna I. Naash8Department of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Surgery, Baylor College of Medicine, Houston, TX 77030, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USADepartment of Biomedical Engineering, College of Engineering, University of Houston, 3517 Cullen Blvd, SERC 2009, Houston, TX 77204, USAGene and drug delivery to the retina is a critical therapeutic goal. While the majority of inherited forms of retinal degeneration affect the outer retina, specifically the photoreceptors and retinal pigment epithelium, effective targeted delivery to this region requires invasive subretinal delivery. Our goal in this work was to evaluate two innovative approaches for increasing both the persistence of delivered nanospheres and their penetration into the outer retina while using the much less invasive intravitreal delivery method. We formulated novel hyaluronic acid nanospheres (HA-NS, 250 nm and 500 nm in diameter) conjugated to fluorescent reporters and delivered them intravitreally to the adult Balb/C mouse retina. They exhibited persistence in the vitreous and along the inner limiting membrane (ILM) for up to 30 days (longest timepoint examined) but little retinal penetration. We thus evaluated the ability of the small molecule, sulfotyrosine, to disrupt the ILM, and found that 3.2 µg/µL sulfotyrosine led to significant improvement in delivery to the outer retina following intravitreal injections without causing retinal inflammation, degeneration, or loss of function. Co-delivery of sulfotyrosine and HA-NS led to robust improvements in penetration of HA-NS into the retina and accumulation along the interface between the photoreceptors and the retinal pigment epithelium. These exciting findings suggest that sulfotyrosine and HA-NS may be an effective strategy for outer retinal targeting after intravitreal injection.https://www.mdpi.com/1999-4923/13/9/1510hyaluronic acid nanospheresretinaphotoreceptorRPEintravitreal injectionsulfotyrosine |
spellingShingle | Aiden Eblimit Mustafa S. Makia Daniel Strayve Ryan Crane Shannon M. Conley Tirthankar Sinha Ghanashyam Acharya Muayyad R. Al-Ubaidi Muna I. Naash Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection Pharmaceutics hyaluronic acid nanospheres retina photoreceptor RPE intravitreal injection sulfotyrosine |
title | Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection |
title_full | Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection |
title_fullStr | Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection |
title_full_unstemmed | Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection |
title_short | Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection |
title_sort | co injection of sulfotyrosine facilitates retinal uptake of hyaluronic acid nanospheres following intravitreal injection |
topic | hyaluronic acid nanospheres retina photoreceptor RPE intravitreal injection sulfotyrosine |
url | https://www.mdpi.com/1999-4923/13/9/1510 |
work_keys_str_mv | AT aideneblimit coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT mustafasmakia coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT danielstrayve coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT ryancrane coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT shannonmconley coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT tirthankarsinha coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT ghanashyamacharya coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT muayyadralubaidi coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection AT munainaash coinjectionofsulfotyrosinefacilitatesretinaluptakeofhyaluronicacidnanospheresfollowingintravitrealinjection |